Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals Market Cap

Recursion Pharmaceuticals has a market cap or net worth of $1.87 billion as of April 26, 2024. Its market cap has increased by 63.94% in one year.

• Market Cap: 1.87B
• Enterprise Value: 1.52B
• 1-Year Change: 63.94%
• Ranking: #2040
• Category: Small-Cap
• Stock Price: $8.12

Market Cap Chart

Since the IPO on April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $2.92B to $1.87B, a decrease of -35.98%. That is a compound annual growth rate of -13.70%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	1.84B	-1.26%
Apr 24, 2024	1.86B	3.12%
Apr 23, 2024	1.81B	1.31%
Apr 22, 2024	1.78B	3.40%
Apr 19, 2024	1.72B	-0.67%
Apr 18, 2024	1.74B	-0.94%
Apr 17, 2024	1.75B	-1.32%
Apr 16, 2024	1.78B	-2.82%
Apr 15, 2024	1.83B	-7.37%
Apr 12, 2024	1.97B	-5.72%
Apr 11, 2024	2.09B	3.96%
Apr 10, 2024	2.01B	-5.61%
Apr 9, 2024	2.13B	1.00%
Apr 8, 2024	2.11B	1.47%
Apr 5, 2024	2.08B	1.61%
Apr 4, 2024	2.05B	-2.24%
Apr 3, 2024	2.10B	1.83%
Apr 2, 2024	2.06B	-6.40%
Apr 1, 2024	2.20B	-6.02%
Mar 28, 2024	2.34B	-1.97%
Mar 27, 2024	2.39B	-1.45%
Mar 26, 2024	2.42B	-2.00%
Mar 25, 2024	2.47B	0.38%
Mar 22, 2024	2.46B	-1.50%
Mar 21, 2024	2.50B	-3.79%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Beam Therapeutics	1.76B
Agios Pharmaceuticals	1.76B
Astrana Health	1.75B
Syndax Pharmaceuticals	1.75B
Catalyst Pharmaceuticals	1.73B
Alphatec Holdings	1.69B
Schrödinger	1.69B
Ginkgo Bioworks Holdings	1.67B